HER2-expressing: 67 Clinical Trials, Page 1 of 7

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Condition(s):HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerLast Updated:May 11, 2022Recruiting

A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer

Condition(s):HER2-expressing CancersLast Updated:April 12, 2022Recruiting

Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast Cancer

Condition(s):Malignant Neoplasm of BreastLast Updated:April 12, 2022Completed

Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers

Condition(s):HER2-expressing CancersLast Updated:March 14, 2022Active, not recruiting

Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors

Condition(s):HER2 Expressing Solid TumorsLast Updated:July 16, 2020Completed

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Condition(s):HER2 Positive Solid TumorsLast Updated:June 23, 2022Recruiting

To Access the Safety and Effects of Intravenous Administration of AMX 818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

Condition(s):Locally Advanced or Metastatic HER2-Expressing CancersLast Updated:July 27, 2022Recruiting

A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers

Condition(s):Advanced Solid TumorsLast Updated:June 30, 2022Enrolling by invitation

A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.

Condition(s):HER2 Expressing Breast or Gastric/Stomach CancersLast Updated:June 18, 2019Completed

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

Condition(s):Locally Advanced Solid Tumor; Metastatic Cancer; Solid Tumor; HER2-positive Gastric Cancer; HER2-positive Metastatic Breast CancerLast Updated:June 27, 2022Recruiting

1 2 3 4 5 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.